ROIV (STOCKS)
Roivant Sciences Ltd. Common Shares
$28.960000
+0.750000 (+2.66%)
Prev close: $28.210000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Matthew Gline
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $20,712.39M
- Employees
- 750
- P/E (TTM)
- -24.78
- P/B (TTM)
- 4.69
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
8
Strong Buy
9
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q3)
|
$-0.38 | $-0.32 | -0.0560 | -17.28% |
|
Sep 2025 (Q2)
|
$-0.17 | $-0.34 | +0.1710 | +50.15% |
|
Jun 2025 (Q1)
|
$-0.33 | $-0.32 | -0.0138 | -4.36% |
|
Mar 2025 (Q4)
|
$-0.29 | $-0.31 | +0.0242 | +7.70% |